NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND GASTROINTESTINAL-DISEASE - PATHOPHYSIOLOGY, TREATMENT AND PREVENTION

被引:19
作者
BJORKMAN, DJ
KIMMEY, MB
机构
[1] University of Utah, School of Medicine, Salt Lake City, UT
[2] University of Washington Medical Center, Seattle, WA
关键词
NONSTEROIDAL; ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL; COMPLICATIONS; GASTRIC ULCER; DUODENAL ULCER; GASTROINTESTINAL BLEEDING;
D O I
10.1159/000171493
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a common cause of gastrointestinal ulceration. Chronic NSAID use increases the risk of ulcer bleeding or perforation 3- to 4-fold. NSAID-induced injury results from both local effects and systemic prostaglandin inhibition. New evidence suggests that the systemic effects on prostaglandin production may vary between NSAIDs. The majority of NSAID-induced ulcers are asymptomatic. They may be treated by discontinuing the NSAID and using standard ulcer therapy. Patients taking NSAIDs who are at a high risk for a GI complication should also receive therapy to decrease their risk for ulceration. In this review the epidemiology, pathogenesis, risks, treatment and prophylaxis of NSAID-induced gastrointestinal complications are discussed.
引用
收藏
页码:119 / 129
页数:11
相关论文
共 81 条
  • [1] Edelson, Tosteson Sax J.T.A.P., Cost-effectivcness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal bleeding, JAMA, 264, pp. 41-47, (1990)
  • [2] Barrier C.H., Hirschowitz B.I., Controversies in the detection and management of nonsteroidal anti-inflammatory drug-induced side effects of the upper gastrointestinal tract, Arthritis Rheum, 32, pp. 926-932, (1989)
  • [3] Langman M., Epidemiologic evidence on the association between peptic ulceration and anti-inflam-matorv drug use, Gastroenterology, 96, pp. 640-646, (1989)
  • [4] Pincus T., Griffin M., Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: New insights from observational studies and functional status questionnaires, Am J Med, 91, pp. 209-212, (1991)
  • [5] Larkai E.N., Smithlidsky J.L., Md Graham D.Y., Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use, Am J Gastroenterol, 82, pp. 1153-1158, (1987)
  • [6] Armstrong C.P., Blower A.L., Non-ste-roidal anti-inflammatory drugs and life threatening complications of peptic ulceration, Gut, 28, pp. 527-532, (1987)
  • [7] Isenberg J.L., Overview of clinical cy-toprotection, Dig Dis Sci, 30, pp. 815-825, (1985)
  • [8] Wilson D.E., Role of prostaglandins in gastroduodenal mucosal protection, J Clin Gastroenterol, 13, pp. 65-71, (1991)
  • [9] Soil A.H., Weinstein W.M., Kurata J., McCarthy D., Nonsteroidal anti-in-flammatory drugs and peptic ulcer disease, Ann Intern Med, 114, pp. 307-319, (1991)
  • [10] Miller T.A., Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms, Am J Physiol, 245, pp. 601-623, (1983)